MediFind
Condition

Acral Dysostosis Dyserythropoiesis Syndrome

Condition 101

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Research section.

Top Global Doctors

HH
Elite
Hermann Heimpel
Ulm, BW, DE
HT
Elite
Hannah Tamary
NL
AI
Elite
Achille Iolascon
IT
RR
Elite
Roberta Russo
Naples, 72, IT
HS
Elite
Hanna Shalev
Beersheba, D, IL
KS
Elite
Klaus B. Schwarz
Ulm, BW, DE

Latest Research

Latest Advance
Study
  • Condition: Congenital Dyserythropoietic Anemia Type I
  • Journal: European journal of haematology
  • Treatment Used: Pegylated interferon ?2a therapy
  • Number of Patients: 7
  • Published —
The study researched the use of Pegylated interferon ?2a therapy in treating congenital dyserythropoietic anemia type I.
Latest Advance
Study
  • Condition: Severe hemosiderosis, disturbed BM microenvironment
  • Journal: Pediatric transplantation
  • Treatment Used: haploidentical bone marrow transplantation with PT-CY
  • Number of Patients: 1
  • Published —
This report describes the case of a twelve year old male with severe hemosiderosis, disturbed bone marrow (BM) microenvironment which lead to experience graft failures.

Clinical Trials

Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 200
  • Start Date: February 23, 2017
French National Registry of Congenital Dyserythropoietic Anemia
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 10000
  • Start Date: July 2016
The Congenital Dyserythropoietic Anemia Registry (CDAR)